News
A Groundbreaking Alzheimer's Blood Test Is Now FDA-Approved
Digest more
Pfizer is paying $1.25 billion to join the PD-(L1)xVEGF bispecific race. | Pfizer is paying $1.25 billion to join the ...
The blood test measures two subtypes of tau and amyloid proteins, which can indicate the presence of amyloid plaque in the ...
The very first blood test for Alzheimer's disease detection has been green-lit by the US Food and Drug Administration (FDA), ...
Fujirebio today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the company’s ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results